Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ANTX | US
-0.12
-3.68%
Healthcare
Biotechnology
30/06/2024
16/04/2026
3.14
3.25
3.25
3.03
AN2 Therapeutics Inc. a clinical-stage biopharmaceutical company focuses on developing treatments for rare chronic and serious infectious diseases. It is developing epetraborole which is in a pivotal Phase 2/3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park California.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
78.9%1 month
83.1%3 months
236.6%6 months
175.6%-
-
0.32
-
-
-2.11
-
-
-
93.71M
93.71M
-
-
-
-
-69.48
0.75
0.98
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.68
Range1M
2.32
Range3M
5.91
Rel. volume
0.79
Price X volume
983.86K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Pyxis Oncology Inc. Common Stock | PYXS | Biotechnology | 1.7 | 101.02M | -0.58% | n/a | 12.29% |
| Agenus Inc | AGEN | Biotechnology | 4.64 | 100.09M | -3.93% | n/a | -170.56% |
| Gossamer Bio Inc | GOSS | Biotechnology | 0.4374 | 98.95M | -2.99% | n/a | 243.93% |
| Surrozen Inc. Common Stock | SRZN | Biotechnology | 30.32 | 97.20M | -5.31% | n/a | 35.73% |
| CannaRoyalty Corp | CNNRF | Biotechnology | 4.73 | 97.00M | 0.42% | n/a | 141.66% |
| GENELUX CORP | GNLX | Biotechnology | 2.77 | 95.66M | -2.46% | n/a | 5.86% |
| NRXPW | NRXPW | Biotechnology | 0.007 | 94.20M | -30.00% | n/a | -46.73% |
| vTv Therapeutics Inc | VTVT | Biotechnology | 36.75 | 89.41M | -2.57% | n/a | 1.55% |
| ALXO | ALXO | Biotechnology | 1.68 | 88.49M | 0.00% | n/a | 10.97% |
| Humacyte Inc | HUMA | Biotechnology | 0.6836 | 85.67M | -7.13% | n/a | -63.37% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.99 | 100.48M | 0.63% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.12 | 99.69M | 0.49% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.93 | 74.70M | 1.14% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.32 | 59.96M | 0.00% | n/a | 5.48% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 14 | 21.32M | 2.04% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.612 | 11.83M | -2.84% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.74 | 10.81M | 6.52% | 0.03 | 16.03% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.335 | 3.41M | -2.06% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2167 | 2.06M | -6.19% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.44 | 793.44K | -17.24% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.11 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.32 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 236.63 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 93.71M | - | Emerging |